Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. [electronic resource] by
- Harrison, C N
- Vannucchi, A M
- Kiladjian, J-J
- Al-Ali, H K
- Gisslinger, H
- Knoops, L
- Cervantes, F
- Jones, M M
- Sun, K
- McQuitty, M
- Stalbovskaya, V
- Gopalakrishna, P
- Barbui, T
Producer: 20170828
In:
Leukemia vol. 30
Availability: No items available.
|
|
8.
|
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. [electronic resource] by
- Harrison, C N
- Vannucchi, A M
- Kiladjian, J-J
- Al-Ali, H K
- Gisslinger, H
- Knoops, L
- Cervantes, F
- Jones, M M
- Sun, K
- McQuitty, M
- Stalbovskaya, V
- Gopalakrishna, P
- Barbui, T
Publication details: Leukemia 03 2017
In:
Leukemia vol. 31
Availability: No items available.
|
|
9.
|
Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. [electronic resource] by
- Passaro, D J
- Waring, L
- Armstrong, R
- Bolding, F
- Bouvier, B
- Rosenberg, J
- Reingold, A W
- McQuitty, M
- Philpott, S M
- Jarvis, W R
- Werner, S B
- Tompkins, L S
- Vugia, D J
Producer: 19970417
In:
The Journal of infectious diseases vol. 175
Availability: No items available.
|